Brief: Homology Medicines Reports Q1 2022 Financial Results And Recent Highlights

Q32 Bio

16/05/2022 22:31

May 16 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
    * Q1 EARNINGS PER SHARE $1.59
    * QTRLY DILUTED NET INCOME PER SHARE WAS $1.59
    * STILL EXPECTS CASH RESOURCES TO FUND OPERATIONS INTO
SECOND HALF
OF 2024
    * Q1 EARNINGS PER SHARE VIEW $-0.35 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8DQd41 
Further company coverage:  FIXX.O 

 ((Reuters.Briefs@thomsonreuters.com;))